GlassScriptPhysician profile
Gregory M Moyer
NPI 1619940947
$1,897.78
in general payments reported to CMS, 2019-2025
25 companies · $409 in 2025
The $409 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $191 · 2021: $171 · 2022: $329 · 2023: $293 · 2024: $196 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $258.74 | 2021-2025 | Qelbree, Qelbree |
| Pfizer INC. | $232.61 | 2019-2025 | |
| Corium, LLC | $219.14 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $143.94 | 2022-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Cranial Technologies, INC | $107.70 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $104.43 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $89.30 | 2019-2022 | |
| Tris Pharma INC | $87.47 | 2019-2025 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $82.04 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $80.71 | 2020-2021 | |
| Neos Therapeutics, LP | $69.78 | 2019-2020 | |
| Seqirus USA INC | $62.82 | 2025 | Flucelvax |
| Dermira, INC. | $51.62 | 2019-2020 | |
| Philips North America LLC | $50.95 | 2022-2025 | Ecc Solutions |
| Sanofi Pasteur INC. | $47.96 | 2019-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $44.25 | 2019 | |
| Neurelis, INC. | $23.81 | 2023 | Valtoco |
| Kaleo, INC. | $23.20 | 2019-2022 | |
| Hologic Sales and Service, LLC | $21.50 | 2025 | Aptima |
| Ars Pharmaceuticals Operations, INC. | $20.64 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $19.40 | 2025 | Pediarix, Bexsero |
| Teva Pharmaceuticals USA, INC. | $16.35 | 2022 | |
| Rhodes Pharmaceuticals L.P. | $15.54 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.53 | 2019 | |
| Vyne Pharmaceuticals INC. | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Moyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.